ロード中...
A phase 1 dose-escalation study: safety, tolerability, and pharmacokinetics of FBS0701, a novel oral iron chelator for the treatment of transfusional iron overload
BACKGROUND: There is still a clinical need for a well-tolerated and safe iron chelator for the treatment of transfusional iron overload. We describe the pharmacokinetic properties and safety data after 7 days of dosing of FBS0701, a novel oral, once-daily iron chelator. DESIGN AND METHODS: This phas...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ferrata Storti Foundation
2011
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3069228/ https://ncbi.nlm.nih.gov/pubmed/21173101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.034405 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|